S&P 500 7,686.14 â–ŧ 25.62 (-0.33%) DOW 53,185.90 â–ŧ 374.10 (-0.70%) NASDAQ 26,370.89 â–ŧ 31.53 (-0.12%) US Markets Closed â€ĸ 08:26 AM ET

POM

Pomdoctor Limited

Price Chart

No historical data available

Latest Quote

$0.95

+0.00 (+0.02%)
Current Price
Previous Close $0.95
Open $0.97
Day High $1.00
Day Low $0.95
Volume 10,376
Fetched: 2026-08-31T02:12:19
Stock Information
Note: Financial values converted from CNY to USD
Total Debt $67.68M
Cash Equivalents $1.43M
Revenue $59.50M
Net Income $-31.63M
Sector Healthcare
Industry Pharmaceutical Retailers
EPS (TTM) $-6.04
Exchange NGM
🌐 Visit Website
Recent Price History
No history data available. Data will be fetched automatically.
About Pomdoctor Limited

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

📰 Latest News
No news articles available at the moment. Check back later for updates on POM.
Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $51,718,765 $43,868,106 $39,593,430 $28,319,956
Cost Of Revenue $51,718,765 $43,868,106 $39,593,430 $28,319,956
Total Revenue $59,496,989 $50,963,746 $45,354,226 $36,481,896
Operating Revenue $59,496,989 $50,963,746 $45,354,226 $36,481,896
Expenses
Interest Expense $1,916,972 $1,928,794 $2,060,390 $2,383,862
Total Expenses $76,810,382 $54,439,593 $48,377,361 $36,974,952
Other Income Expense $-248,857 $-154,367 $-413,592 $-73,575
Other Non Operating Income Expenses $64,835 $178,667 $-174,508 $-73,575
Net Non Operating Interest Income Expense $-1,916,972 $-1,928,794 $-2,060,390 $-2,383,862
Interest Expense Non Operating $1,916,972 $1,928,794 $2,060,390 $2,383,862
Operating Expense $25,091,617 $10,571,487 $8,783,931 $8,654,995
Other Operating Expenses $-22,703 $-28,193 $-47,842 $-41,680
Selling And Marketing Expense $14,314,212 $8,385,865 $6,498,256 $7,060,634
General And Administrative Expense $8,886,181 $1,767,189 $1,832,007 $1,102,255
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-19,479,053 $-5,562,859 $-5,497,274 $-2,950,213
Net Interest Income $-1,916,972 $-1,928,794 $-2,060,390 $-2,383,862
Normalized Income $-19,165,360 $-5,229,824 $-5,258,190 $-2,950,213
Net Income From Continuing And Discontinued Operation $-19,479,053 $-5,562,859 $-5,497,274 $-2,950,213
Total Operating Income As Reported $-17,649,789 $-3,837,074 $-3,310,060 $-534,736
Net Income Common Stockholders $-31,626,267 $-21,328,393 $-21,630,390 $-18,672,671
Net Income $-31,626,267 $-21,328,393 $-21,630,390 $-18,672,671
Net Income Including Noncontrolling Interests $-31,626,493 $-21,324,543 $-21,630,233 $-18,672,951
Net Income From Tax Loss Carryforward $-12,147,214 $-15,765,534 $-16,133,116 $-15,722,459
Net Income Continuous Operations $-19,479,279 $-5,559,009 $-5,497,117 $-2,950,492
Pretax Income $-19,479,223 $-5,559,009 $-5,497,117 $-2,950,492
Special Income Charges $-313,693 $-333,035 $-239,084 $0
Operating Income $-17,313,393 $-3,475,847 $-3,023,135 $-493,056
Gross Profit $7,778,224 $7,095,640 $5,760,796 $8,161,940
Per Share
Diluted EPS $-0.54 $-3.24 $-3.29 $-2.84
Basic EPS $-0.54 $-3.24 $-3.29 $-2.84
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-17,226,345 $-3,277,168 $-3,180,966 $-566,630
Total Unusual Items $-313,693 $-333,035 $-239,084 $0
Total Unusual Items Excluding Goodwill $-313,693 $-333,035 $-239,084 $0
Reconciled Depreciation $22,213 $20,012 $16,676 $0
EBITDA (Bullshit earnings) $-17,540,037 $-3,610,203 $-3,420,050 $-566,630
EBIT $-17,562,250 $-3,630,214 $-3,436,727 $-566,630
Diluted Average Shares $8,641,355 $978,971 $978,971 $978,971
Basic Average Shares $8,641,355 $978,971 $978,971 $978,971
Diluted NI Availto Com Stockholders $-31,626,267 $-21,328,393 $-21,630,390 $-18,672,671
Minority Interests $226 $-3,850 $-157 $280
Tax Provision $56 $0 $0 $0
Write Off $0 $0 $74,387 $0
Impairment Of Capital Assets $313,693 $333,035 $164,697 $0
Research And Development $1,913,928 $446,626 $501,509 $533,786
Selling General And Administration $23,200,392 $10,153,054 $8,330,263 $8,162,889
Other Gand A $8,886,181 $1,767,189 $1,832,007 $1,102,255
Fetched: 2026-08-31
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-67,539,167 $-336,738,559 $-315,409,388 $-293,778,998
Total Assets $16,001,759 $6,877,468 $9,864,838 $7,233,053
Total Non Current Assets $385,444 $1,298,824 $1,025,052 $130,568
Other Non Current Assets $199,987 $123,651 $81,751 $56,181
Non Current Deferred Assets $0 $1,106,534 $854,650 $0
Current Assets $15,616,315 $5,578,644 $8,839,787 $7,102,485
Prepaid Assets $9,266,395 $848,905 $1,120,234 $1,435,044
Inventory $1,231,871 $1,363,659 $1,888,601 $1,219,283
Receivables $3,692,738 $2,227,706 $4,818,529 $4,054,578
Receivables Adjustments Allowances $-337,808 $-398,391 $-294,423 $-215,241
Other Receivables $92,538 $80,061 $69,003 $63,464
Taxes Receivable $529,749 $398,950 $424,913 $0
Accounts Receivable $2,867,162 $1,309,044 $4,261,432 $4,206,356
Allowance For Doubtful Accounts Receivable $-98,540 $-119,964 $-125,965 $0
Gross Accounts Receivable $2,965,703 $1,429,007 $4,387,396 $4,206,356
Cash Cash Equivalents And Short Term Investments $1,425,310 $1,138,374 $999,320 $369,793
Cash And Cash Equivalents $1,425,310 $1,138,374 $999,320 $369,793
Restricted Cash - $0 $13,102 $23,788
Debt
Net Debt $65,835,518 $64,031,044 $60,118,658 $51,459,206
Total Debt $67,683,274 $65,624,827 $61,487,485 $53,743,361
Long Term Debt And Capital Lease Obligation $55,148,469 $54,564,847 $53,055,827 $49,150,577
Long Term Debt $54,955,879 $54,316,064 $52,874,884 $47,448,208
Current Debt And Capital Lease Obligation $12,534,805 $11,059,981 $8,431,657 $4,592,785
Current Debt $12,304,949 $10,853,354 $8,243,094 $4,380,791
Other Current Borrowings $4,419,922 $5,652,459 $4,970,063 $2,886,792
Liabilities
Total Liabilities Net Minority Interest $87,606,237 $318,519,413 $301,673,280 $289,606,662
Total Non Current Liabilities Net Minority Interest $55,148,469 $291,867,207 $276,084,470 $268,241,504
Current Liabilities $32,457,768 $26,652,206 $25,588,809 $21,365,158
Current Deferred Liabilities $236,719 $261,254 $184,990 $406,548
Payables And Accrued Expenses $19,686,244 $15,021,439 $16,972,162 $16,365,826
Interest Payable $6,669,054 $5,467,295 $5,659,720 $4,281,721
Payables $10,847,966 $8,109,105 $9,855,146 $10,612,460
Other Payable $3,912,068 $4,204,994 $3,427,753 $3,864,274
Total Tax Payable $98,040 $121,320 $31,809 $48,973
Accounts Payable $6,668,233 $3,770,884 $6,202,258 $6,448,944
Other Current Liabilities - $309,533 - -
Equity
Common Stock Equity $-67,539,167 $-336,738,559 $-315,409,388 $-293,778,998
Total Equity Gross Minority Interest $-71,604,478 $-311,641,945 $-291,808,442 $-282,373,609
Stockholders Equity $-67,539,167 $-336,738,559 $-315,409,388 $-293,778,998
Other Equity Interest $-325 $-239 $-239 -
Gains Losses Not Affecting Retained Earnings $-260,721 $-778 $0 -
Other Equity Adjustments $-260,721 $-778 - -
Retained Earnings $-368,364,462 $-336,738,196 $-315,409,803 $-293,779,413
Preferred Securities Outside Stock Equity $0 $237,302,360 $223,028,643 $219,090,927
Other
Ordinary Shares Number $3,449,025 $2,936,914 $2,936,914 $2,936,914
Share Issued $3,449,025 $2,936,914 $2,936,914 $2,936,914
Tangible Book Value $-67,539,167 $-336,738,559 $-315,409,388 $-293,778,998
Invested Capital $-278,338 $-271,569,141 $-254,291,410 $-241,949,999
Working Capital $-16,841,453 $-21,073,562 $-16,749,023 $-14,262,673
Capital Lease Obligations $422,446 $455,410 $369,506 $1,914,362
Total Capitalization $-12,583,287 $-282,422,495 $-262,534,504 $-246,330,790
Minority Interest $-4,065,311 $25,096,614 $23,600,947 $11,405,389
Additional Paid In Capital $301,083,901 $0 - -
Capital Stock $2,441 $654 $654 $415
Common Stock $2,441 $654 $654 $415
Long Term Capital Lease Obligation $192,590 $248,783 $180,943 $1,702,369
Current Deferred Revenue $236,719 $261,254 $184,990 $406,548
Current Capital Lease Obligation $229,856 $206,627 $188,564 $211,994
Line Of Credit $7,885,027 $5,200,895 $3,273,030 $1,493,999
Current Accrued Expenses $8,838,278 $6,912,333 $7,117,016 $5,753,366
Dueto Related Parties Current $169,625 $11,907 $193,327 $250,269
Net PPE $185,457 $68,639 $88,650 $0
Accumulated Depreciation $-1,619,241 $-1,609,532 $-1,590,474 $-1,593,780
Gross PPE $1,804,698 $1,678,171 $1,679,124 $1,593,780
Leases $708,006 $708,006 $708,006 $722,214
Machinery Furniture Equipment $1,096,691 $970,165 $971,118 $871,566
Properties $0 $0 $0 $0
Inventories Adjustments Allowances $-280,236 $-73,563 $-74,845 -
Finished Goods $1,512,107 $1,437,222 $1,963,446 $1,219,283
Duefrom Related Parties Current $541,097 $838,043 $357,605 -
Investments And Advances - - $0 $74,387
Fetched: 2026-08-31
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-22,239,854 $-2,405,477 $-6,829,858 $-3,275,604
Operating Activities
Operating Cash Flow $-22,089,927 $-2,399,857 $-6,813,211 $-3,275,604
Cash Flow From Continuing Operating Activities $-22,089,927 $-2,399,857 $-6,813,211 $-3,275,604
Operating Gains Losses - $-579 - -
Investing Activities
Capital Expenditure $-149,928 $-5,620 $-16,646 -
Investing Cash Flow $-239,192 $-4,965 $-16,646 $0
Cash Flow From Continuing Investing Activities $-239,192 $-4,965 $-16,646 $0
Net Other Investing Changes $-89,264 - - -
Financing Activities
Issuance Of Capital Stock $24,388,927 $0 $0 -
Financing Cash Flow $22,900,308 $2,531,552 $7,448,699 $3,346,222
Cash Flow From Continuing Financing Activities $22,900,308 $2,531,552 $7,448,699 $3,346,222
Net Other Financing Charges $-3,580,030 - $-338,748 -
Net Common Stock Issuance $24,388,927 $0 $0 -
Common Stock Issuance $24,388,927 $0 $0 -
Other
Repayment Of Debt $-11,406,844 $-10,152,627 $-12,528,275 $-1,924,479
Issuance Of Debt $13,498,255 $12,684,179 $20,315,722 $5,270,701
Interest Paid Supplemental Data $402,226 $408,354 $355,276 $481,407
Income Tax Paid Supplemental Data $0 $0 $0 $0
End Cash Position $1,425,310 $1,138,374 $1,012,422 $393,581
Beginning Cash Position $1,138,374 $1,012,422 $393,581 $322,963
Effect Of Exchange Rate Changes $-284,253 $-778 $0 -
Changes In Cash $571,189 $126,730 $618,841 $70,618
Net Issuance Payments Of Debt $2,091,411 $2,531,552 $7,787,447 $3,346,222
Net Short Term Debt Issuance $2,684,133 $1,927,864 $1,835,204 $1,275,527
Short Term Debt Payments $-5,647,217 $-4,633,073 $-2,330,471 $-226,823
Short Term Debt Issuance $8,331,350 $6,560,938 $4,165,675 $1,502,351
Net Long Term Debt Issuance $-592,722 $603,688 $5,952,243 $2,070,695
Long Term Debt Payments $-5,759,627 $-5,519,554 $-10,197,804 $-1,697,656
Long Term Debt Issuance $5,166,905 $6,123,242 $16,150,048 $3,768,350
Net PPE Purchase And Sale $-149,928 $-4,965 $-16,646 $0
Sale Of PPE $0 $655 $0 $0
Purchase Of PPE $-149,928 $-5,620 $-16,646 $0
Change In Working Capital $-5,634,356 $2,607,901 $-1,868,144 $-209,894
Change In Other Working Capital $-24,535 $76,264 $-221,558 $189,903
Change In Other Current Liabilities $-645,293 $149,445 $-296,701 $-373,050
Change In Other Current Assets $12,928 $-41,900 $-25,570 $0
Change In Payables And Accrued Expense $5,017,662 $-764,219 $90,434 $4,147,455
Change In Accrued Expense $724,186 $-12,258 $-14,349 $68,687
Change In Payable $4,293,476 $-751,961 $104,783 $4,078,769
Change In Account Payable $2,897,349 $-2,431,374 $-246,686 $1,925,362
Change In Tax Payable $-23,280 $89,436 $-17,164 $-4,801
Change In Income Tax Payable $-23,280 $89,436 $-17,164 $-4,801
Change In Prepaid Assets $37,189 $290,230 $-7,989 $-183,322
Change In Inventory $-148,448 $451,379 $-744,163 $-11,539
Change In Receivables $-9,883,861 $2,446,703 $-662,597 $-3,979,341
Changes In Account Receivables $-1,563,105 $2,958,389 $-189,468 $-3,882,597
Stock Based Compensation $2,443,419 $0 $0 -
Provisionand Write Offof Assets $244,384 $198,783 $296,289 $-115,218
Asset Impairment Charge $313,693 $333,035 $239,084 $0
Depreciation Amortization Depletion $22,213 $20,012 $16,676 $0
Depreciation And Amortization $22,213 $20,012 $16,676 $0
Depreciation $22,213 $20,012 $16,676 $0
Gain Loss On Sale Of PPE $0 $-579 $0 -
Net Income From Continuing Operations $-19,479,279 $-5,559,009 $-5,497,117 $-2,950,492
Net Investment Purchase And Sale - - - $0
Purchase Of Investment - - - $0
Amortization Cash Flow - - - $0
Amortization Of Intangibles - - - $0
Fetched: 2026-08-31